DermaVir Patch: Phase II started

Genetic Immunity began a placebo-controlled, German Phase II trial to evaluate 2, 4, or 8 DermaVir Patches of 0.1 mg DNA per patch every 6 weeks for 18 weeks in 36 treatment-naïve HIV-1 infected patie...